You are currently viewing October 2022
1 results showing for: 'glecaprevir with pibrentasvir'
Tab 100 mg with pibrentasvir 40 mg
- Brand Maviret
- Subsidy $24750.00
- Measure / Qty per 84
Note: the supply of treatment is via Pharmac’s approved direct distribution supply. Further details can be found on Pharmac’s website https://www.pharmac.govt.nz/maviret.
- Rectangle page icon symoblising a PDF. PDF
- Two duplicate pages icon. Click to copy
- Restriction. Restriction
- HSS Hospital Supply Status
- PSS Principal Supply Status
- dv DV Limit Gives the maximum volume that can be purchased of other brands
Email firstname.lastname@example.org to provide feedback: compliments, suggestions and complaints about the Online Pharmaceutical Schedule.